Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 87 companies set new 52-week lows.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Tempest Therapeutics (NASDAQ:TPST) shares increased by 8.19% to $6.6 during Thursday's after-market session. The company's market cap stands at $45.6 million.
Tempest Therapeutics Q3 EPS $(1.21) Up From $(11.22) YoY
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(1.21) per share. This is a 89.22 percent increase over losses of $(11.22) per share from the same period last year.
Tempest Announces Presentation At Society For Immunotherapy Of Cancer (SITC) 36th Annual Meeting On Nov. 10-14
Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, today announced the acceptance of
Tempest Enters Into Exclusive License Agreement With The University Of California For Novel Cancer Target
Tempest Therapeutics, Inc. (NASDAQ:TPST), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, today announced that it has
Tempest Therapeutics Q2 EPS $(7.63) Up From $(11.42) YoY
Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(7.63) per share. This is a 33.19 percent increase over losses of $(11.42) per share from the same period last year.